Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-06-15 | Mr. John Adam ZangerleSenior VP, General Counsel & Secretary | -1,42k | 296,97k | Vente | 209,28 | 35,26k | -3,87% |
| 2026-06-04 | Mr. John Adam ZangerleSenior VP, General Counsel & Secretary | -401,00 | 85,11k | Sale to Issuer | 212,24 | 36,68k | -1,08% |
| 2026-06-04 | Mr. Renato G. TamaroVP & Corporate Treasurer | -65,00 | 13,80k | Sale to Issuer | 212,24 | 6,19k | -1,04% |
| 2026-06-04 | Ms. Julia K. MadsenSenior VP & GM of Life Sciences | -195,00 | 41,39k | Sale to Issuer | 212,24 | 12,26k | -1,57% |
| 2026-06-04 | Mr. Kenneth E. KohlerSenior VP & GM of AST | -150,00 | 31,84k | Sale to Issuer | 212,24 | 11,33k | -1,31% |
| 2026-06-04 | Ms. Mary Clare FraserSVP & Chief HR Officer | -600,00 | 127,34k | Sale to Issuer | 212,24 | 13,72k | -4,19% |
| 2026-06-04 | Mr. Daniel A. CarestioPresident, CEO & Director | -1,89k | 400,92k | Sale to Issuer | 212,24 | 63,65k | -2,88% |
| 2026-06-04 | Mr. Daniel A. CarestioPresident, CEO & Director | -4,43k | 946,80k | Vente | 212,00 - 214,64 | 63,65k | -6,50% |
| 2026-06-04 | Ms. Karen L. BurtonSenior VP, CFO & CAO | -90,00 | 19,10k | Sale to Issuer | 212,24 | 13,18k | -0,68% |
| 2026-06-03 | Ms. Julia K. MadsenSenior VP & GM of Life Sciences | -239,00 | 50,24k | Sale to Issuer | 210,19 | 12,45k | -1,88% |
| 2026-06-03 | Mr. Renato G. TamaroVP & Corporate Treasurer | -64,00 | 13,45k | Sale to Issuer | 210,19 | 6,26k | -1,01% |
| 2026-06-03 | Mr. John Adam ZangerleSenior VP, General Counsel & Secretary | -365,00 | 76,72k | Sale to Issuer | 210,19 | 37,08k | -0,97% |
| 2026-06-03 | Mr. Kenneth E. KohlerSenior VP & GM of AST | -184,00 | 38,67k | Sale to Issuer | 210,19 | 11,48k | -1,58% |
| 2026-06-03 | Ms. Mary Clare FraserSVP & Chief HR Officer | -311,00 | 65,37k | Sale to Issuer | 210,19 | 14,32k | -2,13% |
| 2026-06-03 | Ms. Karen L. BurtonSenior VP, CFO & CAO | -190,00 | 39,94k | Sale to Issuer | 210,19 | 13,27k | -1,41% |
| 2026-06-03 | Mr. Daniel A. CarestioPresident, CEO & Director | -2,62k | 550,49k | Sale to Issuer | 210,19 | 69,96k | -3,61% |
| 2026-06-02 | Mr. Renato G. TamaroVP & Corporate Treasurer | -41,00 | 8,60k | Sale to Issuer | 209,76 | 6,32k | -0,64% |
| 2026-06-02 | Mr. John Adam ZangerleSenior VP, General Counsel & Secretary | -247,00 | 51,81k | Sale to Issuer | 209,76 | 37,44k | -0,66% |
| 2026-06-02 | Ms. Julia K. MadsenSenior VP & GM of Life Sciences | -127,00 | 26,64k | Sale to Issuer | 209,76 | 12,69k | -0,99% |
| 2026-06-02 | Mr. Cary L. MajorsSenior VP & President of Healthcare | -67,00 | 14,05k | Sale to Issuer | 209,76 | 17,41k | -0,38% |
| 2026-06-02 | Ms. Lindsey McGowanVP, Chief Compliance & Quality Officer | -329,00 | 69,01k | Sale to Issuer | 209,76 | 5,91k | -5,27% |
| 2026-06-02 | Ms. Mary Clare FraserSVP & Chief HR Officer | -591,00 | 123,97k | Sale to Issuer | 209,76 | 14,63k | -3,88% |
| 2026-06-02 | Mr. Kenneth E. KohlerSenior VP & GM of AST | -66,00 | 13,84k | Sale to Issuer | 209,76 | 11,67k | -0,56% |
| 2026-06-02 | Mr. Daniel A. CarestioPresident, CEO & Director | -995,00 | 208,71k | Sale to Issuer | 209,76 | 72,58k | -1,35% |
| 2026-06-02 | Ms. Karen L. BurtonSenior VP, CFO & CAO | -66,00 | 13,84k | Other Disposition | 209,76 | 13,46k | -0,49% |
| 2026-06-02 | Mr. Richard Carroll BreedenIndependent Director | 2,30k | 164,22k | Derivative Exercise and Retained Stock | 71,40 | 38,96k | 6,27% |
| 2026-06-02 | Mr. Richard Carroll BreedenIndependent Director | -1,48k | 204,54k | Derivative Exercise and Sale | 71,40 - 209,51 | 38,96k | - |
| 2026-06-01 | Ms. Lindsey McGowanVP, Chief Compliance & Quality Officer | -198,00 | 0,00 | Sale to Issuer | - | 5,09k | -3,75% |
| 2026-06-01 | Mr. Renato G. TamaroVP & Corporate Treasurer | -81,00 | 0,00 | Sale to Issuer | - | 5,61k | -1,42% |
| 2026-06-01 | Mr. John Adam ZangerleSenior VP, General Counsel & Secretary | -337,00 | 0,00 | Sale to Issuer | - | 33,33k | -1,00% |
| 2026-06-01 | Mr. Cary L. MajorsSenior VP & President of Healthcare | -768,00 | 0,00 | Sale to Issuer | - | 12,73k | -5,69% |
| 2026-06-01 | Ms. Julia K. MadsenSenior VP & GM of Life Sciences | -208,00 | 0,00 | Sale to Issuer | - | 10,50k | -1,94% |
| 2026-06-01 | Mr. Daniel A. CarestioPresident, CEO & Director | -1,25k | 0,00 | Sale to Issuer | - | 49,84k | -2,45% |
| 2026-06-01 | Ms. Mary Clare FraserSVP & Chief HR Officer | -673,00 | 0,00 | Sale to Issuer | - | 12,21k | -5,22% |
| 2026-06-01 | Mr. Kenneth E. KohlerSenior VP & GM of AST | -109,00 | 0,00 | Sale to Issuer | - | 9,53k | -1,13% |
| 2026-06-01 | Ms. Karen L. BurtonSenior VP, CFO & CAO | -99,00 | 0,00 | Sale to Issuer | - | 8,21k | -1,19% |
| 2026-03-05 | Ms. Cynthia L. FeldmannIndependent Director | -3,10k | 262,99k | Derivative Exercise and Sale | 152,32 - 237,21 | 9,37k | - |
| 2025-11-21 | Ms. Julia K. MadsenSenior VP & GM of Life Sciences | -5,01k | 669,96k | Derivative Exercise and Sale | 114,22 - 262,00 | 10,71k | - |
| 2025-11-18 | Mr. Renato G. TamaroVP & Corporate Treasurer | -3,54k | 266,07k | Derivative Exercise and Sale | 182,22 - 258,03 | 5,70k | - |
| 2025-11-18 | Mr. Renato G. TamaroVP & Corporate Treasurer | -1,50k | 386,64k | Vente | 257,76 | 5,70k | -20,85% |
| 2025-11-11 | Mr. John Adam ZangerleSenior VP, General Counsel & Secretary | -15,00k | 2,93M | Derivative Exercise and Sale | 69,72 - 265,14 | 33,67k | - |
| 2025-10-06 | Mr. Daniel A. CarestioPresident, CEO & Director | -159,00 | 38,45k | Vente | 241,82 | 51,10k | -0,31% |
| 2025-10-01 | Mr. Renato G. TamaroVP & Corporate Treasurer | -26,00 | 0,00 | Sale to Issuer | - | 7,20k | -0,36% |
| 2025-10-01 | Mr. John Adam ZangerleSenior VP, General Counsel & Secretary | -91,00 | 0,00 | Sale to Issuer | - | 33,67k | -0,27% |
| 2025-10-01 | Mr. Cary L. MajorsSenior VP & President of Healthcare | -303,00 | 0,00 | Sale to Issuer | - | 13,49k | -2,20% |
| 2025-10-01 | Ms. Mary Clare FraserSVP & Chief HR Officer | -207,00 | 0,00 | Sale to Issuer | - | 12,88k | -1,58% |
| 2025-10-01 | Ms. Julia K. MadsenSenior VP & GM of Life Sciences | -52,00 | 0,00 | Sale to Issuer | - | 10,71k | -0,48% |
| 2025-10-01 | Ms. Karen L. BurtonSenior VP, CFO & CAO | -39,00 | 0,00 | Sale to Issuer | - | 8,30k | -0,47% |
| 2025-10-01 | Mr. Daniel A. CarestioPresident, CEO & Director | -130,00 | 0,00 | Sale to Issuer | - | 51,26k | -0,25% |
| 2025-08-20 | Mr. Renato G. TamaroVP & Corporate Treasurer | -3,20k | 327,42k | Derivative Exercise and Sale | 147,05 - 249,24 | 7,22k | - |
| 2025-08-13 | Mr. Richard Carroll BreedenIndependent Director | 4,11k | 263,25k | Derivative Exercise and Retained Stock | 64,05 | 36,66k | 12,63% |
| 2025-08-11 | Dr. Mohsen M. SohiIndependent Chairman of the Board | -4,11k | 731,21k | Derivative Exercise and Sale | 64,05 - 241,96 | 22,36k | - |
| 2025-08-11 | Ms. Cynthia L. FeldmannIndependent Director | -3,50k | 844,25k | Derivative Exercise and Sale | 241,56 | 9,37k | - |
| 2025-08-11 | Ms. Karen L. BurtonSenior VP, CFO & CAO | -7,90k | 1,01M | Derivative Exercise and Sale | 114,22 - 241,73 | 5,99k | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
